Viewing Study NCT04559295


Ignite Creation Date: 2025-12-24 @ 1:58 PM
Ignite Modification Date: 2025-12-31 @ 3:55 AM
Study NCT ID: NCT04559295
Status: UNKNOWN
Last Update Posted: 2020-09-22
First Post: 2020-08-31
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Bone Marrow Concentrate (BMC) Injection in Intervertebral Discs
Sponsor: Stem Cures
Organization:

Study Overview

Official Title: Study of Bone of Marrow Concentrate (BMC) Injection in Discs, Facets, Sacroiliac Joints, and Epidural Space for Chronic Lower Back Pain With and Without Radiculopathy
Status: UNKNOWN
Status Verified Date: 2020-09
Last Known Status: ACTIVE_NOT_RECRUITING
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Intradiscal delivery of bone marrow concentrate (BMC) into discs, facet, epidural space, and sacroiliac joints
Detailed Description: To study if the outcomes for the injection of bone marrow concentrate (BMC) in patients with disc, facet, epidural space, and sacroiliac joint pain create a clinically meaningful improvement in pain and function. Further analysis will determine if there be any variance in patient reported outcome due to the individual's pre-procedure cell count and analysis.

Hypothesis 1: An injection of autologous BMC into discs, facets, sacroiliac joints, and epidural space will improve pain and function in patients with IDD

Hypothesis 2: There will be a direct relationship between an individual's BMC composition and the patient's reported outcomes

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: True
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: